Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Gracell Biotechnologies (GRCL)
NASDAQ:GRCL
Gracell Biotechnologies (GRCL) Stock Price & Analysis
90 Followers
GRCL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.40 - $5.69
Previous Close$3.06
Volume86.25K
Average Volume (3M)111.14K
Market Cap
$207.16M
Enterprise Value$22.27M
Total Cash (Recent Filing)¥211.42M
Total Debt (Recent Filing)¥26.53M
Price to Earnings (P/E)-2.4
Beta-0.38
Next Earnings
Aug 15, 2023EPS Estimate
-$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.30
Shares Outstanding67,720,000
10 Day Avg. Volume145,687
30 Day Avg. Volume111,135
Standard Deviation0.28
R-Squared0.12
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.13
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$12.25Price Target Upside300.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Gracell Biotechnologies News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GRCL FAQ
What was Gracell Biotechnologies’s price range in the past 12 months?
Gracell Biotechnologies lowest stock price was $1.40 and its highest was $5.69 in the past 12 months.
What is Gracell Biotechnologies’s market cap?
Currently, no data Available
When is Gracell Biotechnologies’s upcoming earnings report date?
Gracell Biotechnologies’s upcoming earnings report date is Aug 15, 2023 which is in 71 days.
How were Gracell Biotechnologies’s earnings last quarter?
Gracell Biotechnologies released its earnings results on May 15, 2023. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of -$0.069 by -$0.001.
Is Gracell Biotechnologies overvalued?
According to Wall Street analysts Gracell Biotechnologies’s price is currently Undervalued.
Does Gracell Biotechnologies pay dividends?
Gracell Biotechnologies does not currently pay dividends.
What is Gracell Biotechnologies’s EPS estimate?
Gracell Biotechnologies’s EPS estimate is -$0.07.
How many shares outstanding does Gracell Biotechnologies have?
Gracell Biotechnologies has 67,715,240 shares outstanding.
What happened to Gracell Biotechnologies’s price movement after its last earnings report?
Gracell Biotechnologies reported an EPS of -$0.07 in its last earnings report, missing expectations of -$0.069. Following the earnings report the stock price went up 9.314%.
Which hedge fund is a major shareholder of Gracell Biotechnologies?
Among the largest hedge funds holding Gracell Biotechnologies’s share is Viking Global Investors LP. It holds Gracell Biotechnologies’s shares valued at N/A.
---
Gracell Biotechnologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.25 (300.33% Upside)
$12.25 (300.33% Upside)
Hedge Fund Trend
Decreased
By 491.6K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
12.08%
12-Months-Change
Fundamentals
Return on Equity
-39.90%
Trailing 12-Months
Asset Growth
-29.64%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Gracell Biotechnologies
Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfil unmet medical needs in the treatment of cancer.
---
Top 5 ETFs holding GRCL
iShares Biotechnology ETF
$897.30K
Invesco Golden Dragon China ETF
$195.56K
iShares NASDAQ US Biotechnology UCITS ETF
$92.96K
Invesco Nasdaq Biotechnology ETF
$3.55K
Up to five ETFs with an Outperform Smart Score that hold GRCL. The ETFs are listed according to market value of GRCL within the ETF
---
---